TCI Wealth Advisors, Inc. - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 140 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$3,320
-33.6%
193
+206.3%
0.00%
-100.0%
Q4 2021$5,000
+25.0%
630.0%0.00%0.0%
Q3 2021$4,000
+100.0%
63
+40.0%
0.00%
Q2 2021$2,0000.0%45
+7.1%
0.00%
-100.0%
Q1 2021$2,000420.00%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,664,409$177,556,0004.47%
Avidity Partners Management LP 2,493,800$166,187,0003.68%
Matrix Capital Management Company, LP 4,349,279$289,836,0003.30%
Integral Health Asset Management, LLC 90,000$5,998,0001.72%
Affinity Asset Advisors, LLC 77,500$5,165,0001.30%
Ghost Tree Capital, LLC 65,000$4,332,0001.27%
Ikarian Capital, LLC 200,000$13,328,0000.94%
HighVista Strategies LLC 20,596$1,373,0000.91%
SILVERARC CAPITAL MANAGEMENT, LLC 23,855$1,590,0000.90%
Woodline Partners LP 507,847$33,843,0000.55%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders